This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a McGill University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $956,250
Development of radiotwin 18F/177Lu theranostic radiopharmaceuticals targeting gastrin-releasing peptide receptor (GRPR)
CIHR · 2023 · Principal investigator
Development of radiotwin 18F/177Lu theranostic radiopharmaceuticals targeting gastrin-releasing peptide receptor (GRPR)
Principal investigators: Kostikov, Alexey; Lumb, Jean-Philip G; Sadeghi, Saman
Keywords: Breast Cancer; Fluorine-18; Gastrin-Releasing Peptide Receptor (Grpr); Heterocyclic Silicon Fluoride Acceptors (Hetsifa); Lutetium-177; Positron Emission Tomography (Pet); Prostate Cancer; Radioligand Therapy (Rlt); Theranostic Radiopharmaceuticals
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.